• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过小干扰RNA沉默特定的SARS蛋白(7a/7b、3a/3b和S蛋白)抑制SARS-CoV复制周期

Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.

作者信息

Akerström Sara, Mirazimi Ali, Tan Yee-Joo

机构信息

Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.

出版信息

Antiviral Res. 2007 Mar;73(3):219-27. doi: 10.1016/j.antiviral.2006.10.008. Epub 2006 Nov 7.

DOI:10.1016/j.antiviral.2006.10.008
PMID:17112601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7114101/
Abstract

The severe acute respiratory syndrome coronavirus (SARS CoV) genome has 14 potential open reading frames (ORFs). The first ORF is translated from the full-length genomic mRNA while the remaining ORFs are translated from eight subgeomic RNAs (sgRNAs). In this study, we designed small interference RNAs (siRNAs) targeting sgRNA 2, 3 and 7 and tested their efficiency and specificity in silencing the protein translated from the targeted sgRNA. Our results demonstrated that siRNA 7 could inhibit sgRNA 7, which showed 19/19 nucleotides (nt) matching, and sgRNA 8, which showed 18/19 nt matching; but, it did not inhibit the full-length genomic mRNA which showed 17/19 nt matching. Overall, each of the siRNAs can inhibit the targeted sgRNA without affecting the full-length genomic mRNA or the other sgRNAs that showed mismatch of two or more nt. Thus, siRNA could be designed so as to knockdown the expression of viral protein(s) from a targeted sgRNA during viral infection, thereby allowing the contribution of individual viral proteins to viral infection to be delineated. When Vero E6 cells expressing siRNA 2, 3 or 7 were infected with SARS-CoV, a significant reduction in the yield of progeny virus was observed. Indirect immunofluorescence assays showed that in the infected cells expressing each of the siRNAs, there was aspecific silencing of S, 3a and 7a, respectively, but the expression of nucleocapsid protein was not affected. Thus, our data suggests that the accessory proteins, i.e. 3a and 7a, could play an important role during the replication cycle of the SARS-CoV.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)基因组有14个潜在的开放阅读框(ORF)。第一个ORF由全长基因组mRNA翻译而来,其余的ORF则由8个亚基因组RNA(sgRNA)翻译而来。在本研究中,我们设计了靶向sgRNA 2、3和7的小干扰RNA(siRNA),并测试了它们在沉默靶向sgRNA翻译的蛋白质方面的效率和特异性。我们的结果表明,siRNA 7可以抑制sgRNA 7(显示19/19个核苷酸(nt)匹配)和sgRNA 8(显示18/19 nt匹配);但是,它不抑制全长基因组mRNA(显示17/19 nt匹配)。总体而言,每个siRNA都可以抑制靶向的sgRNA,而不影响全长基因组mRNA或其他显示两个或更多nt错配的sgRNA。因此,可以设计siRNA,以便在病毒感染期间敲低靶向sgRNA的病毒蛋白表达,从而能够描绘出单个病毒蛋白对病毒感染的贡献。当用SARS-CoV感染表达siRNA 2、3或7的Vero E6细胞时,观察到子代病毒产量显著降低。间接免疫荧光分析表明,在表达每种siRNA的感染细胞中,分别存在S、3a和7a的特异性沉默,但核衣壳蛋白的表达未受影响。因此,我们的数据表明,辅助蛋白,即3a和7a,可能在SARS-CoV的复制周期中发挥重要作用。

相似文献

1
Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.通过小干扰RNA沉默特定的SARS蛋白(7a/7b、3a/3b和S蛋白)抑制SARS-CoV复制周期
Antiviral Res. 2007 Mar;73(3):219-27. doi: 10.1016/j.antiviral.2006.10.008. Epub 2006 Nov 7.
2
siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.靶向严重急性呼吸综合征冠状病毒前导序列的小干扰RNA抑制病毒复制。
Gene Ther. 2005 May;12(9):751-61. doi: 10.1038/sj.gt.3302479.
3
Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.利用质粒介导的干扰RNA抑制严重急性呼吸综合征相关冠状病毒的复制和感染
Antivir Ther. 2005;10(4):527-33.
4
Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis.严重急性呼吸综合征冠状病毒 viroporins E、3a 和 8a 在复制和发病机制中的作用。
mBio. 2018 May 22;9(3):e02325-17. doi: 10.1128/mBio.02325-17.
5
Inhibition of SARS-CoV replication by siRNA.小干扰RNA对严重急性呼吸综合征冠状病毒复制的抑制作用
Antiviral Res. 2005 Jan;65(1):45-8. doi: 10.1016/j.antiviral.2004.09.005.
6
Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.通过RNA干扰沉默培养细胞中SARS-CoV刺突蛋白的表达。
FEBS Lett. 2004 Feb 27;560(1-3):141-6. doi: 10.1016/S0014-5793(04)00087-0.
7
Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.小干扰RNA在哺乳动物细胞中对严重急性呼吸综合征病毒复制的抑制作用
J Virol. 2004 Jul;78(14):7523-7. doi: 10.1128/JVI.78.14.7523-7527.2004.
8
SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.严重急性呼吸综合征冠状病毒在人传导气道上皮细胞体外模型中的复制及致病机制
Virus Res. 2008 Apr;133(1):33-44. doi: 10.1016/j.virusres.2007.03.013. Epub 2007 Apr 23.
9
Structure, expression, and intracellular localization of the SARS-CoV accessory proteins 7a and 7b.严重急性呼吸综合征冠状病毒附属蛋白7a和7b的结构、表达及细胞内定位
Adv Exp Med Biol. 2006;581:115-20. doi: 10.1007/978-0-387-33012-9_20.
10
Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus.了解严重急性呼吸综合征(SARS)冠状病毒特有的辅助病毒蛋白。
Antiviral Res. 2006 Nov;72(2):78-88. doi: 10.1016/j.antiviral.2006.05.010. Epub 2006 Jun 6.

引用本文的文献

1
Advancements in the development of antivirals against SARS-Coronavirus.抗SARS冠状病毒抗病毒药物的研发进展。
Front Cell Infect Microbiol. 2025 Jan 23;15:1520811. doi: 10.3389/fcimb.2025.1520811. eCollection 2025.
2
Potential Therapeutic Options for COVID-19.2019冠状病毒病的潜在治疗选择
Infect Microbes Dis. 2020 Jul 16;2(3):89-95. doi: 10.1097/IM9.0000000000000033. eCollection 2020 Sep.
3
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的ORF3a蛋白作为抗2019冠状病毒病(COVID-19)及感染后长期影响的治疗靶点

本文引用的文献

1
Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus.了解严重急性呼吸综合征(SARS)冠状病毒特有的辅助病毒蛋白。
Antiviral Res. 2006 Nov;72(2):78-88. doi: 10.1016/j.antiviral.2006.05.010. Epub 2006 Jun 6.
2
Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.严重急性呼吸综合征冠状病毒属特异性开放阅读框编码在细胞培养物和小鼠中复制的非必需功能。
J Virol. 2005 Dec;79(23):14909-22. doi: 10.1128/JVI.79.23.14909-14922.2005.
3
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
Pathogens. 2024 Jan 14;13(1):75. doi: 10.3390/pathogens13010075.
4
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.从针对 SARS-CoV-2 的全基因组 RNAi 分子筛选到经过验证的广谱强效预防药物。
Commun Biol. 2023 Mar 16;6(1):277. doi: 10.1038/s42003-023-04589-5.
5
SARS-CoV-2 accessory protein 7b forms homotetramers in detergent.SARS-CoV-2 辅助蛋白 7b 在去污剂中形成同源四聚体。
Virol J. 2022 Nov 21;19(1):193. doi: 10.1186/s12985-022-01920-0.
6
Development and application of ribonucleic acid therapy strategies against COVID-19.针对 COVID-19 的核糖核酸治疗策略的开发和应用。
Int J Biol Sci. 2022 Aug 1;18(13):5070-5085. doi: 10.7150/ijbs.72706. eCollection 2022.
7
The ORF7a protein of SARS-CoV-2 initiates autophagy and limits autophagosome-lysosome fusion via degradation of SNAP29 to promote virus replication.SARS-CoV-2 的 ORF7a 蛋白通过降解 SNAP29 启动自噬并限制自噬体-溶酶体融合,从而促进病毒复制。
Autophagy. 2023 Feb;19(2):551-569. doi: 10.1080/15548627.2022.2084686. Epub 2022 Jun 19.
8
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的RNA干扰(RNAi)分子全基因组筛选产生了一种广泛有效的预防措施。
bioRxiv. 2022 Apr 12:2022.04.12.488010. doi: 10.1101/2022.04.12.488010.
9
Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19.了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)开放阅读框3a(ORF3a)在病毒致病机制及冠状病毒病2019(COVID-19)中的作用。
Front Microbiol. 2022 Mar 9;13:854567. doi: 10.3389/fmicb.2022.854567. eCollection 2022.
10
Investigational antiviral drugs for the treatment of COVID-19 patients.用于治疗 COVID-19 患者的抗病毒药物研究。
Arch Virol. 2022 Mar;167(3):751-805. doi: 10.1007/s00705-022-05368-z. Epub 2022 Feb 9.
在恒河猴中使用小干扰RNA(siRNA)进行针对严重急性呼吸综合征冠状病毒的预防和治疗方案。
Nat Med. 2005 Sep;11(9):944-51. doi: 10.1038/nm1280. Epub 2005 Aug 21.
4
G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells.严重急性呼吸综合征冠状病毒3b蛋白在转染细胞中诱导的G0/G1期阻滞和细胞凋亡。
Virol J. 2005 Aug 17;2:66. doi: 10.1186/1743-422X-2-66.
5
Nucleolar localization of non-structural protein 3b, a protein specifically encoded by the severe acute respiratory syndrome coronavirus.非结构蛋白3b的核仁定位,非结构蛋白3b是一种由严重急性呼吸综合征冠状病毒特异性编码的蛋白质。
Virus Res. 2005 Dec;114(1-2):70-9. doi: 10.1016/j.virusres.2005.06.001. Epub 2005 Jul 25.
6
Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.利用质粒介导的干扰RNA抑制严重急性呼吸综合征相关冠状病毒的复制和感染
Antivir Ther. 2005;10(4):527-33.
7
The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells.严重急性呼吸综合征相关冠状病毒的3a蛋白可诱导Vero E6细胞凋亡。
J Gen Virol. 2005 Jul;86(Pt 7):1921-1930. doi: 10.1099/vir.0.80813-0.
8
Coronaviral hypothetical and structural proteins were found in the intestinal surface enterocytes and pneumocytes of severe acute respiratory syndrome (SARS).在严重急性呼吸综合征(SARS)患者的肠道表面肠上皮细胞和肺细胞中发现了冠状病毒的假定蛋白和结构蛋白。
Mod Pathol. 2005 Nov;18(11):1432-9. doi: 10.1038/modpathol.3800439.
9
siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.靶向严重急性呼吸综合征冠状病毒前导序列的小干扰RNA抑制病毒复制。
Gene Ther. 2005 May;12(9):751-61. doi: 10.1038/sj.gt.3302479.
10
The protein X4 of severe acute respiratory syndrome-associated coronavirus is expressed on both virus-infected cells and lung tissue of severe acute respiratory syndrome patients and inhibits growth of Balb/c 3T3 cell line.严重急性呼吸综合征相关冠状病毒的X4蛋白在严重急性呼吸综合征患者的病毒感染细胞和肺组织中均有表达,并抑制Balb/c 3T3细胞系的生长。
Chin Med J (Engl). 2005 Feb 20;118(4):267-74.